PIK3CA and neoplasm: MS analysis was used to test 158 mutations of major EGFR, KRAS, BRAF, ALK, PIK3CA, ERBB2, DDR2, AKT, and MEK1 oncogenes in 92 NSCLC tumor samples and in 13 plasma samples.